Parent-reported subjective complaints in children using antiepileptic drugs: What do they mean?

Epilepsy and Behavior

Volumn 3, Issue 4, 2002, Pages 322-329

  Carpay, Johannes A ^a,g   Vermeulen, Jan ^b   Stroink, Hans ^c   Brouwer, Oebele F ^d   Boudewyn Peters, A C ^e   Aldenkamp, Albert P ^f   Van Donselaar, Cees A ^c   Arts, Willem F M ^a,c  

^a JULIANA CHILDREN S HOSPITAL   (Netherlands)

^b Epilepsy Center Meer en Bosch   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^g Gooi Noord Hospital   (Netherlands)

Author keywords

Antiepileptic drugs; Children; Epilepsy; Parents; Quality of life scale; Side effects

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; NITRAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ANOREXIA; ARTICLE; BEHAVIOR DISORDER; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DEFECATION DISORDER; DEPRESSION; DIPLOPIA; DISEASE ASSOCIATION; DISEASE SEVERITY; DROWSINESS; EPILEPSY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTIVARIATE ANALYSIS; PARENT; QUANTITATIVE ANALYSIS; RATING SCALE; SCORING SYSTEM; SEIZURE; SOMNOLENCE; SPEECH DISORDER; VERTIGO; VISUAL IMPAIRMENT;

EID: 0036669658     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-5050(02)00047-1     Document Type: Article

References (19)

1. Carpay JA, Arts WFM, et al. Epilepsy in childhood: an audit of clinical practice. Arch Neurol 1998;55:668-73.
2. Berg AT, Levy SR, Testa FM, Shinnar S. Treatment of newly diagnosed pediatric epilepsy: a community-based study. Arch Pediatr Adolesc Med 1999;153:1267-71.
3. Verity CM, Hosking G, Easter DJ. The paediatric EPITEG collaborative group: a multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. Dev Med Child Neurol 1995;37:97-108.
4. Aldenkamp AP, Alpherts WC, Sandstedt P, et al. Antiepileptic drug-related cognitive complaints in seizure-free children with epilepsy before and after drug discontinuation. Epilepsia 1998;39:1070-4.
5. Carpay JA, Vermeulen J, Stroink H, et al. Parent-completed scales for measuring severity of seizures and side effects of antiepileptic drugs in childhood epilepsy: development and psychometric analysis. Epilepsy Res 1996;24:173-81.
6. Carpay JA, Vermeulen J, Stroink H, et al. Seizure severity in children with epilepsy: a parent-completed scale compared with clinical data. Epilepsia 1997;38:346-52.
7. Carpay JA, Vermeulen J, Stroink H, et al. Disability due to restrictions in childhood epilepsy. Dev Med Child Neurol 1997;39:521-6.
8. Commission on Classification and Terminology of the ILAE. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
9. Deckers CLP, Hekster YA, Keyser A, Meinardi H, Renier WO. Drug load in clinical trials: a neglected factor. Clin Pharmacol Ther 1997;62:592-5.
10. AbuArafeh IA, Wallace SJ. Unwanted effects of antiepileptic drugs. Dev Med Child Neurol 1988;30:115-25.
11. Herranz JL, Armijo JA, Arteaga R. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children. Epilepsia 1988;29:794-804.
12. de Silva M, MacArdle B, McGowan M, et al. Randomized comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996;347:709-13.
13. Deckers CLP, Hekster YA, Keyser A, van Lier HJJ, Meinardi H, Renier WO. Monotherapy versus polytherapy: a multicenter double-blind randomized study. Epilepsia 2001;42:1387-94.
14. Aicardi J. Epilepsy in children. International review of child neurology series. New York: Raven Press; 1994.
15. Austin JK, Shelton Smith M, Risinger MW, McNelis AM. Childhood epilepsy and asthma: comparison of quality of life. Epilepsia 1994;35:608-15.
16. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997;38:353-62.
17. O'Dell C, Lightstone L, Shinnar S, Moshe SL, Carpay JA, Arts WFM. Impact of childhood seizures on quality of life: perceptions of parents and children. Epilepsia 1998;39(S6):223.
18. Gillham R, Baker G, Thompson P, et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Res 1996;24:47-55.
19. Brooks J, Baker GA, Aldenkamp AP. The A-B neuropsychological assessment schedule (ABNAS): the further refinement of a patient-based scale of patient-perceived cognitive functioning. Epilepsy Res 2001;43:227-37.